// App-Quantinova.ai

: Are Global Coagulation Assays Better Measures of the Intensity of Anticoagulation in Patients with Antiphospholipid Syndrome?

Researchers

Presenter

  • W.H. Wong

Principal Investigators

  • M.C. Kong

  • E.J.S. See

  • S.H. Yeang

  • S.K. Koh

  • Y.T. Shim

  • C.W. Tan

  • H.J. Ng

Medical Centers

  • Singapore General Hospital, Singapore, Singapore

  • Singapore General Hospital, Singapore, Singapore

  • Singapore General Hospital, Singapore, Singapore

Locations

  • Singapore

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Antiphospholipid syndrome

  • Deep vein thrombosis

  • Arrhythmia

  • Venous thrombosis

Biomarkers

  • Catalase

Drug/Treatment

  • Evithrom

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved